Sublocade Will No Longer Be Available in Australia After December 2026
Contrôle des drogues
02 Juil 2026
People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.
What is happening?
The manufacturer, Indivior, has announced that Sublocade, a long-acting injectable buprenorphine, will be discontinued in Australia. Their decision is based on commercial and operational reasons. It is not because of any new concerns about the medicine’s safety, quality or effectiveness.
The last planned supply of Sublocade in Australia is 11 December 2026. Existing stock will continue to be available while supplies last, and PBS claims can continue until 31 December 2026.
What does this mean if you are receiving Sublocade?
There is still time to plan your ongoing care.
Speak with your prescribing doctor or clinic, they can work with you to discuss your options and develop a plan that meets your needs.
Will other long-acting injectable buprenorphine medicines still be available?
Yes. The current announcement only affects Sublocade.
Buvidal will continue to be available.
Need someone to talk to?
We know that changes to opioid dependence treatment can be stressful, and we know this announcement may create uncertainty for many people. Speak with your prescribing doctor or clinic about your options and next steps, and
if you need further support, your local peer-based Drug User Organisation is here to help.
| État ou territoire | Organisation des consommateurs de drogues |
|---|---|
| Territoire de la capitale australienne | Alliance de Canberra pour la minimisation des risques et la défense des droits (CAHMA) : (02) 6253 3643 |
| Nouvelle-Galles du Sud | NUAA’s Peerline: 1800 644 413 |
| Territoire du Nord | NTAHC: (08) 8944 7777 |
| Queensland | QuIVAA’s PeerQnect: 1800 175 889 |
| Australie du Sud | SA Harm Reduction Peer Services (SAhrps): 1800 437 222 ou (08) 83628443 |
| Tasmanie | Tasmanian Users and Health Support League (TUHSL): 02 5110 000 |
| Victoria | Harm Reduction Victoria (HRVic)/Service de médiation pour la défense de la pharmacothérapie (PAMS) : 1800 443 844 |
| Australie occidentale | Peer Based Harm Reduction Western Australian (PBHR WA): (08) 9325 8387 |

Contrôle des drogues
02 Juil 2026
Sublocade Will No Longer Be Available in Australia After December 2026

Contrôle des drogues
02 Juil 2026
Sublocade Will No Longer Be Available in Australia After December 2026
People who are currently on Sublocade may have heard that it will no longer be available in Australia as of 11 December 2026. We know this news is worrying, and many people will have questions about what it means for them and their loved ones.

Contrôle des drogues
08 avril 2026
Les groupes de test de pilules réduits au silence par Meta et TikTok alors que les stocks de drogues toxiques prolifèrent
Les réseaux sociaux doivent cesser d'urgence de censurer les avertissements concernant les médicaments qui sauvent des vies. Plusieurs organisations, dont Pill Testing Australia, CanTEST et leur partenaire néo-zélandais Know Your Stuff NZ, ont vu leurs publications supprimées, leurs comptes suspendus et, dans certains cas, des pages entières et des comptes personnels définitivement effacés, après que des systèmes automatisés de modération de contenu ont signalé leurs alertes de santé publique comme faisant la promotion de la consommation de drogues.

Contrôle des drogues
24 février 2026
Le rapport de la troisième année fait état d'une pureté accrue des médicaments et d'une réduction des substitutions, tandis que le service de contrôle des médicaments de Canberra renforce la surveillance mondiale.
Le premier service australien de dépistage de drogues en site fixe, CanTEST Health and Drug Checking Service, continue de démontrer la valeur croissante du dépistage de drogues pour la santé publique, en fournissant des données d'alerte précoce essentielles aux réponses locales, nationales et internationales aux nouveaux risques liés aux drogues.
